Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1703186

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1703186

Competent Cells Global Market Report 2025

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Competent cells are bacterial cells that have been treated to become capable of taking up foreign deoxyribonucleic acid (DNA). These cells are crucial in molecular biology for cloning and transformation experiments, as they facilitate the introduction of genetic material into the cells. The main goal of using competent cells is to enable the uptake of foreign DNA during the transformation process.

The primary types of competent cells are chemically competent cells, electrocompetent cells, and ultracompetent cells. Chemically competent cells are prepared through chemical treatments that increase their membrane permeability, allowing DNA to enter more easily. These cells are utilized in various applications such as cloning, protein expression, and mutagenesis. They are employed by a range of end users including contract research organizations, pharmaceutical and biotechnology companies, and academic research institutions.

The competent cells market research report is one of a series of new reports from The Business Research Company that provides competent cells market statistics, including competent cells industry global market size, regional shares, competitors with a competent cells market share, detailed competent cells market segments, market trends and opportunities, and any further data you may need to thrive in the competent cells industry. This competent cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The competent cells market size has grown rapidly in recent years. It will grow from $2.65 billion in 2024 to $3.01 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to increasing demand for genetic cloning, increasing government funding for life sciences research, growth in the biotechnology workforce, increasing focus on rare disease research, and rise in outsourcing research activities to contract research organizations.

The competent cells market size is expected to see rapid growth in the next few years. It will grow to $4.97 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, increasing investment in biotechnology startups, increasing demand for recombinant protein production, increasing prevalence of chronic diseases, and increasing demand for industrial biotechnology solutions. Major trends in the forecast period include technological advancements, artificial intelligence, quantum computing, 5G technology, and wearable technology.

The expanding biopharmaceutical industry is expected to drive the growth of the competent cells market in the coming years. The biopharmaceutical industry focuses on the development, production, and commercialization of drugs derived from biological sources, utilizing biotechnology and molecular biology to create innovative therapies and treatments. This industry is growing due to rapid advancements in biotechnology, increasing demand for personalized medicine, and rising investments in research and development for novel therapies. Competent cells play a critical role in the biopharmaceutical industry by supporting genetic engineering, gene cloning, and protein expression, which are essential for producing recombinant proteins, therapeutic enzymes, and other biologics used in drug development. For example, in May 2024, the Pharmaceutical Research and Manufacturers of America (PhRMA), a US-based trade association, reported that the U.S. biopharmaceutical industry generated over $800 billion in direct output in 2022, contributing around 1.6% to the GDP and accounting for 17.6% of all domestic business R&D activity. Thus, the growth of the biopharmaceutical industry is driving the expansion of the competent cells market.

Key companies in the competent cells market are introducing innovative kits, such as replication competent lentivirus kits, to improve cell and gene therapies and enhance the efficiency of genetic transformation processes. Cell and gene therapies involve modifying or using cells or genes to treat or cure diseases. For instance, Bio-Rad Laboratories Inc., a US-based clinical diagnostics manufacturer, released the Vericheck ddPCR replication competent lentivirus kit and the Vericheck ddPCR replication competent AAV kit in February 2024. These kits utilize advanced droplet digital PCR (ddPCR) technology to detect and quantify replication-competent lentivirus (RCL) and adeno-associated virus (AAV) with high sensitivity and precision. This technology is vital for ensuring the safety and effectiveness of viral vectors used in therapeutic applications by detecting and eliminating potentially harmful replication-competent viruses.

In June 2024, JumpCode Genomics Inc., a US-based biotechnology company, formed a partnership with Takara Bio USA, Inc. to merge their core intellectual property (IP) for CRISPR-based targeted removal of unwanted transcripts, such as ribosomal RNAs, from next-generation sequencing (NGS) libraries. Through this collaboration, JumpCode Genomics and Takara Bio USA aim to combine their patented CRISPR-based technologies to enhance research applications, including those related to competent cells, by improving the removal of undesired sequences from biological samples. This will increase the precision and cost-effectiveness of genomics and molecular biology studies. Takara Bio USA Inc. is a US-based biotechnology company specializing in the development, manufacturing, and distribution of research reagents, instruments, and competent cells.

Major companies operating in the competent cells market are Thermo Fisher Scientific Inc., Avantor Inc., Agilent Technologies Inc., Sigma-Aldrich, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, GenScript Biotech Corporation, Takara Bio Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., HiMedia Laboratories Pvt. Ltd., Zymo Research Corporation, Lucigen Corporation, Meridian Bioscience Inc., Codex DNA Inc., OriGene Technologies Inc., SERVA Electrophoresis GmbH, SMOBIO Technology Inc., Yeastern Biotech Co. Ltd., Scarab Genomics LLC, Enzynomics Co. Ltd., NZYTech Lda., Gold Biotechnology Inc., Abyntek Biopharma S.L

North America was the largest region in the competent cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the competent cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the competent cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The competent cells market consists of sales of specialized competent cells, transformation kits, ready-to-use competent cells kits, and competent strain-specific cells. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Competent Cells Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on competent cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for competent cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The competent cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Chemically Competent Cells; Electrocompetent Cells; Ultracompetent Cells
  • 2) By Application: Cloning; Protein Expression; Mutagenesis; Other Applications
  • 3) By End User: Contract Research Organizations; Pharmaceutical And Biotechnology Companies; Academic Research Institutes; Other End-Users

Subsegments

  • 1) By Chemically Competent Cells: E. Coli Competent Cells; Bacillus Subtilis Competent Cells
  • 2) By Electrocompetent Cells: E. Coli Electrocompetent Cells; Other Bacterial Electrocompetent Cells
  • 3) By Ultracompetent Cells: E. Coli Ultracompetent Cells; Other Ultracompetent Cell Types
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Avantor Inc.; Agilent Technologies Inc.; Sigma-Aldrich; Bio-Rad Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r29846

Table of Contents

1. Executive Summary

2. Competent Cells Market Characteristics

3. Competent Cells Market Trends And Strategies

4. Competent Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Competent Cells Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Competent Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Competent Cells Market Growth Rate Analysis
  • 5.4. Global Competent Cells Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Competent Cells Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Competent Cells Total Addressable Market (TAM)

6. Competent Cells Market Segmentation

  • 6.1. Global Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chemically Competent Cells
  • Electrocompetent Cells
  • Ultracompetent Cells
  • 6.2. Global Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloning
  • Protein Expression
  • Mutagenesis
  • Other Applications
  • 6.3. Global Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Contract Research Organizations
  • Pharmaceutical And Biotechnology Companies
  • Academic Research Institutes
  • Other End-Users
  • 6.4. Global Competent Cells Market, Sub-Segmentation Of Chemically Competent Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • E. Coli Competent Cells
  • Bacillus Subtilis Competent Cells
  • 6.5. Global Competent Cells Market, Sub-Segmentation Of Electrocompetent Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • E. Coli Electrocompetent Cells
  • Other Bacterial Electrocompetent Cells
  • 6.6. Global Competent Cells Market, Sub-Segmentation Of Ultracompetent Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • E. Coli Ultracompetent Cells
  • Other Ultracompetent Cell Types

7. Competent Cells Market Regional And Country Analysis

  • 7.1. Global Competent Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Competent Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Competent Cells Market

  • 8.1. Asia-Pacific Competent Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Competent Cells Market

  • 9.1. China Competent Cells Market Overview
  • 9.2. China Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Competent Cells Market

  • 10.1. India Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Competent Cells Market

  • 11.1. Japan Competent Cells Market Overview
  • 11.2. Japan Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Competent Cells Market

  • 12.1. Australia Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Competent Cells Market

  • 13.1. Indonesia Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Competent Cells Market

  • 14.1. South Korea Competent Cells Market Overview
  • 14.2. South Korea Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Competent Cells Market

  • 15.1. Western Europe Competent Cells Market Overview
  • 15.2. Western Europe Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Competent Cells Market

  • 16.1. UK Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Competent Cells Market

  • 17.1. Germany Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Competent Cells Market

  • 18.1. France Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Competent Cells Market

  • 19.1. Italy Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Competent Cells Market

  • 20.1. Spain Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Competent Cells Market

  • 21.1. Eastern Europe Competent Cells Market Overview
  • 21.2. Eastern Europe Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Competent Cells Market

  • 22.1. Russia Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Competent Cells Market

  • 23.1. North America Competent Cells Market Overview
  • 23.2. North America Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Competent Cells Market

  • 24.1. USA Competent Cells Market Overview
  • 24.2. USA Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Competent Cells Market

  • 25.1. Canada Competent Cells Market Overview
  • 25.2. Canada Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Competent Cells Market

  • 26.1. South America Competent Cells Market Overview
  • 26.2. South America Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Competent Cells Market

  • 27.1. Brazil Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Competent Cells Market

  • 28.1. Middle East Competent Cells Market Overview
  • 28.2. Middle East Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Competent Cells Market

  • 29.1. Africa Competent Cells Market Overview
  • 29.2. Africa Competent Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Competent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Competent Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Competent Cells Market Competitive Landscape And Company Profiles

  • 30.1. Competent Cells Market Competitive Landscape
  • 30.2. Competent Cells Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Avantor Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sigma-Aldrich Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Competent Cells Market Other Major And Innovative Companies

  • 31.1. QIAGEN N.V.
  • 31.2. Promega Corporation
  • 31.3. GenScript Biotech Corporation
  • 31.4. Takara Bio Inc.
  • 31.5. New England Biolabs Inc.
  • 31.6. TransGen Biotech Co. Ltd.
  • 31.7. HiMedia Laboratories Pvt. Ltd.
  • 31.8. Zymo Research Corporation
  • 31.9. Lucigen Corporation
  • 31.10. Meridian Bioscience Inc.
  • 31.11. Codex DNA Inc.
  • 31.12. OriGene Technologies Inc.
  • 31.13. SERVA Electrophoresis GmbH
  • 31.14. SMOBIO Technology Inc.
  • 31.15. Yeastern Biotech Co. Ltd.

32. Global Competent Cells Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Competent Cells Market

34. Recent Developments In The Competent Cells Market

35. Competent Cells Market High Potential Countries, Segments and Strategies

  • 35.1 Competent Cells Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Competent Cells Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Competent Cells Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!